WATTS RYAN J. (President and CEO) sold 66.2% of their position (495.28K shares) of DENALI THERAPEUTICS INC. on the open market
Open‑market sale worth $7.43M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/11/2025ACC: 0001714899-25-000149
DirectorOfficer· President and CEO
Since Aug 2018
-495.28K
Net shares
Net seller
$7.43M
Total sold
1
Open market trades
0B · 1S
5
Total transactions
495.28K acquired · 990.56K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+455.28K
Price / share
$0.68
Trade value
$309.59K
% of position
179.9%
7/9/2025
253.07K→708.35K
Common Stock
Direct
Shares
+40K
Price / share
$5.28
Trade value
$211.20K
% of position
5.6%
7/9/2025
708.35K→748.35K
Common Stock
Direct
Shares
−495.28K
Price / share
$15.00
Trade value
$7.43M
% of position
66.2%
7/9/2025
748.35K→253.07K
Total
Net shares
+0.00
Net value
-$6.91M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2025 | M · Option Exercise | +455.28K | $0.68 | $309.59K | 179.9% | 253.07K | 708.35K |
| Common Stock Direct | 7/9/2025 | M · Option Exercise | +40K | $5.28 | $211.20K | 5.6% | 708.35K | 748.35K |
| Common Stock Direct | 7/9/2025 | S · Sale | −495.28K | $15.00 | $7.43M | 66.2% | 748.35K | 253.07K |
| Total | +0.00 | -$6.91M | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
455.28K shares
Shares
−455.28K
Strike price
0.68
Held after
622.81K
Exercisable
—
7/9/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
5.28
Held after
20.37K
Exercisable
—
7/9/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock455.28K shares | 7/9/2025 | M · Option Exercise | −455.28K | 0.68 | — | 622.81K |
| Stock Option (right to buy) Direct | Common Stock40K shares | 7/9/2025 | M · Option Exercise | −40K | 5.28 | — | 20.37K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.20M
Total
2.20M indirect2.20M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.20M | Indirect |
| Total | 2.20M | 2.20M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported